BOSTON (Reuters) - Vertex Pharmaceuticals Inc said on Tuesday it will discontinue development of an experimental drug to treat hepatitis C after it failed to show sufficient efficacy. The company, which was developing the oral drug, known as ALS-2...
Source: http://health.yahoo.net/news/s/nm/vertex-ends-work-on-one-hepatitis-c-drug-continues-another
Grand Slam Troy Davis Eugene Murphy Jr. Libya
No comments:
Post a Comment
Note: only a member of this blog may post a comment.